Clinical Trials Logo

Clinical Trial Summary

Most children with type 1 diabetes have a drop in the blood sugar during exercise. This drop in the blood sugar can result in hypoglycemia (low blood sugar). In children using an insulin pump, there is an opportunity to reduce the basal insulin rate during exercise. This study is being conducted to determine if decreasing the insulin that is received during exercise will reduce the risk of hypoglycemia. We hope to learn more about how the body responds to hypoglycemia and to hyperglycemia (high blood sugar) when it occurs.

As part of the study, children will have a visit on two different days. During each visit, children will exercise on a treadmill for about 60 minutes. During one of the visits, the children's basal rate will be continued during the exercise. During one visit, the basal insulin will be stopped. The blood sugar will be checked frequently during the exercise.


Clinical Trial Description

Each child will have two study visits. The visits will be between 1 and 4 weeks apart. The child will come to the research unit at the hospital at about 11:30 a.m. and will have lunch in the clinic.

- If the child has had a severe hypoglycemia episode in the 2 weeks before a visit or is ill at the time of either visit, the visit will be rescheduled.

The parent and child will be asked if they want to use a meter to test the child's hemoglobin A1c at home. If they want to do this, they will be given the meter and asked to test the child's A1c two times on the day before one of the visits. The two tests will be done at the same time and they will also be asked to check the child's blood sugar at the same time. The test involves a fingerstick similar to testing the blood sugar level with a home glucose meter.

At the start of each visit, a continuous glucose sensor will be inserted under the skin. This is done either in the stomach area, side, or buttock depending on which area looks like it will work best for the child. A special cream may be used to numb the skin before this sensor is placed. At the end of each visit, the child will have the option of removing the sensor or wearing it home for continued use.

During each visit, blood samples will be drawn frequently to measure glucose and other hormones. To make the blood sampling easier, a small tube, called a catheter, will be placed in a vein in the child's arm. A special cream may be used to numb the skin before the tube is placed. The tube will stay in the vein while the child is in the hospital. There may be some itching, stinging or pain from having the tube in the vein. However, there should be no pain when blood is drawn through the tube. If the tube stops working, a new one will need to be inserted.

- Blood sugar measurements will also be made with a home glucose meter. Instead of doing fingersticks, blood may be taken from the tube to measure the blood glucose with the home glucose meter.

- Blood samples will be taken and sent to a lab before, during, and after the exercise.

- In all, there will be 24 blood samples taken (12 samples during each of the visits).

During each visit, the child will be asked to walk on a treadmill.

- Before and after walking on the treadmill, the child will be checked for urine and blood ketones.

- During each visit, in the late afternoon, the child will walk on the treadmill for 15 minutes followed by a 5-minute rest period. This cycle of 15 minutes of exercise followed by a 5-minute rest period will be repeated 3 times for a total of 75 minutes.

- During one of the visits, the child's basal insulin rate will be stopped at the start of the exercise session and will be restarted about 45 minutes after the child stops exercising. During the other visit, the basal rate will be continued. A process like flipping a coin is used to decide the order of the visits.

- For both visits, the blood sugar needs to be between 120 and 200 at the start of the exercise. Between lunch and 4 p.m., the blood sugar will be checked a few times. To lower the blood sugar to this range, the child may be given insulin through the catheter to be used to draw the blood samples. No bolus insulin doses will be given with the child's pump after lunch. If the study doctors or nurses think the child's blood sugar may be too low to start exercise, a snack may be given to get the blood sugar to be in this range. If the blood sugar is too high or too low and cannot be corrected quickly enough, the exercise for that day may be postponed. If this happens, the child will need to return on another day.

- About 30 minutes after the exercise has ended, the child's blood sugar will be checked. If it is less than 250 mg/dL, a snack will be given and the last blood draw for the study will be made 15 minutes later. If the blood sugar is 250 mg/dL or higher, no snack will be given and the child's blood sugar will be checked in 15 minutes. At that time the child's insulin pump will be started if it was stopped, and a correction dose of insulin may be given.

- If at anytime after the exercise session the child's blood sugar is 325 mg/dL or higher, the child's insulin pump will be started and a correction dose of insulin may be given.

During each visit, the child's blood sugar will be checked frequently. If the blood sugar drops to 65 mg/dL or lower, the hypoglycemia will be treated with carbohydrate. The child will not be treated if the blood sugar is higher than 65 mg/dL.

Dinner will be given to the child at about 6:00 p.m. A bedtime snack will be given to the child to take home. The snack will be based on what the child would normally eat on a day with exercise.

The child will be instructed to not have any more exercise for the rest of the day. The child will be given a home glucose meter and asked to check his or her blood sugar prior to the bedtime snack, at midnight, 3 a.m., and before breakfast the next morning. The child will be asked to treat any blood sugars 80 mg/dL or lower and to record the information on a log that will be provided.

If the parent and child decided to do the A1c meter study at home, at one of the visits the study staff will check the A1c using the meter and the DCA2000. A fingerstick blood sample will also be sent to the central laboratory. The child's blood sugar will also be checked at the time of the tests.

The catheter for the blood draws will be removed and each visit will end at about 6:30 p.m. ;


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00147342
Study type Observational
Source Jaeb Center for Health Research
Contact
Status Completed
Phase N/A
Start date May 2005
Completion date December 2005

See also
  Status Clinical Trial Phase
Completed NCT00351234 - Carnitine Levels and Carnitine Supplementation in Type I Diabetes N/A
Recruiting NCT00875290 - The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children Phase 3
Completed NCT00888628 - Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients Phase 1/Phase 2
Completed NCT00493935 - Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia N/A
Completed NCT00118976 - Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease N/A
Active, not recruiting NCT02081326 - Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes Phase 2
Completed NCT00109434 - Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes N/A
Withdrawn NCT00790439 - Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant Phase 2
Completed NCT00789308 - Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation Phase 2
Completed NCT02970357 - Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes N/A
Completed NCT02521675 - Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions N/A
Completed NCT01781975 - Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus Phase 2
Completed NCT00368394 - Dose-Exposure-Response in Type 1 Diabetes Mellitus Phase 1
Terminated NCT04591925 - SteadiSetâ„¢ Pilot Study (SteP Study) N/A
Not yet recruiting NCT06147583 - Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes N/A
Active, not recruiting NCT00306098 - Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression Phase 2
Recruiting NCT05708820 - Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control N/A
Completed NCT02556554 - Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy N/A
Completed NCT00652288 - Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs Phase 1